PPARγ and NOTCH Regulate Regional Identity in the Murine Cardiac Outflow Tract.
Autor: | Rammah M; Aix Marseille University, CNRS UMR 7288, IBDM, Marseille, France (M.R., M.T.R., R.S., F.R., R.G.K.)., Théveniau-Ruissy M; Aix Marseille University, CNRS UMR 7288, IBDM, Marseille, France (M.R., M.T.R., R.S., F.R., R.G.K.).; Aix Marseille Univ, INSERM, MMG, Marseille, France (M.T.R., F.R.)., Sturny R; Aix Marseille University, CNRS UMR 7288, IBDM, Marseille, France (M.R., M.T.R., R.S., F.R., R.G.K.)., Rochais F; Aix Marseille University, CNRS UMR 7288, IBDM, Marseille, France (M.R., M.T.R., R.S., F.R., R.G.K.).; Aix Marseille Univ, INSERM, MMG, Marseille, France (M.T.R., F.R.)., Kelly RG; Aix Marseille University, CNRS UMR 7288, IBDM, Marseille, France (M.R., M.T.R., R.S., F.R., R.G.K.). |
---|---|
Jazyk: | angličtina |
Zdroj: | Circulation research [Circ Res] 2022 Oct 28; Vol. 131 (10), pp. 842-858. Date of Electronic Publication: 2022 Oct 07. |
DOI: | 10.1161/CIRCRESAHA.122.320766 |
Abstrakt: | Background: The arterial pole of the heart is a hotspot for life-threatening forms of congenital heart defects (CHDs). Development of this cardiac region occurs by addition of Second Heart Field (SHF) progenitor cells to the embryonic outflow tract (OFT) and subsequently the base of the ascending aorta and pulmonary trunk. Understanding the cellular and genetic mechanisms driving arterial pole morphogenesis is essential to provide further insights into the cause of CHDs. Methods: A synergistic combination of bioinformatic analysis and mouse genetics as well as embryo and explant culture experiments were used to dissect the cross-regulatory transcriptional circuitry operating in future subaortic and subpulmonary OFT myocardium. Results: Here, we show that the lipid sensor PPARγ (peroxisome proliferator-activated receptor gamma) is expressed in future subpulmonary myocardium in the inferior wall of the OFT and that PPARγ signaling-related genes display regionalized OFT expression regulated by the transcription factor TBX1 (T-box transcription factor 1). Modulating PPARγ activity in ex vivo cultured embryos treated with a PPARγ agonist or antagonist or deleting Pparγ in cardiac progenitor cells using Mesp1-Cre reveals that Pparγ is required for addition of future subpulmonary myocardium and normal arterial pole development. Additionally, the non-canonical DLK1 (delta-like noncanonical Notch ligand 1)/NOTCH (Notch receptor 1)/HES1 (Hes family bHLH transcription factor 1) pathway negatively regulates Ppar γ in future subaortic myocardium in the superior OFT wall. Conclusions: Together these results identify Pparγ as a regulator of regional transcriptional identity in the developing heart, providing new insights into gene interactions involved in congenital heart defects. |
Databáze: | MEDLINE |
Externí odkaz: |